You just read:

The Heart Rhythm Society and Boehringer Ingelheim Pharmaceuticals, Inc. award $500,000 in grants to support quality improvement innovation in atrial fibrillation and stroke prevention

News provided by

Heart Rhythm Society

May 06, 2016, 13:00 ET